News Home

Where Does Iovance Biotherapeutics Inc (IOVA) Stock Fall in the Biotechnology Field After It Has Risen 20.33% This Week?

Monday, February 12, 2024 09:45 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does Iovance Biotherapeutics Inc (IOVA) Stock Fall in the Biotechnology Field After It Has Risen 20.33% This Week?

Iovance Biotherapeutics Inc (IOVA) is around the top of the Biotechnology industry according to InvestorsObserver. IOVA received an overall rating of 74, which means that it scores higher than 74 percent of all stocks. Iovance Biotherapeutics Inc also achieved a score of 88 in the Biotechnology industry, putting it above 88 percent of Biotechnology stocks. Biotechnology is ranked 20 out of the 148 industries.

Overall Score - 74
IOVA has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on IOVA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 74 means the stock is more attractive than 74 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Iovance Biotherapeutics Inc Stock Today?

Iovance Biotherapeutics Inc (IOVA) stock has risen 3.81% while the S&P 500 is lower by -0.01% as of 9:44 AM on Monday, Feb 12. IOVA is higher by $0.35 from the previous closing price of $9.18 on volume of 79,091 shares. Over the past year the S&P 500 has risen 21.48% while IOVA is higher by 32.55%. IOVA lost -$2.08 per share the over the last 12 months. Click Here to get the full Stock Report for Iovance Biotherapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App